Northern Trust Corp Amicus Therapeutics, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 3,183,987 shares of FOLD stock, worth $32.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,183,987

Previous 3,047,354 4.48%

Holding current value

$32.3 Million

Previous $30.2 Million 12.49%

% of portfolio

0.01%

Previous 0.01%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$9.55 - $12.09 $1.3 Million - $1.65 Million	136,633 Added 4.48%	3,183,987 $34 Million
Q2 2024 Aug 14, 2024	SELL	$9.04 - $11.75 $982,901 - $1.28 Million	-108,728 Reduced 3.45%	3,047,354 $30.2 Million
Q1 2024 May 14, 2024	BUY	$11.43 - $14.24 $3.56 Million - $4.43 Million	311,331 Added 10.94%	3,156,082 $37.2 Million
Q4 2023 Feb 13, 2024	BUY	$9.97 - $14.52 $127,825 - $186,160	12,821 Added 0.45%	2,844,751 $40.4 Million
Q3 2023 Nov 13, 2023	BUY	$11.78 - $13.86 $183,862 - $216,326	15,608 Added 0.55%	2,831,930 $34.4 Million
Q2 2023 Aug 11, 2023	BUY	$10.72 - $13.3 $1.07 Million - $1.32 Million	99,488 Added 3.66%	2,816,322 $35.4 Million
Q1 2023 May 15, 2023	BUY	$10.91 - $13.54 $210,137 - $260,793	19,261 Added 0.71%	2,716,834 $30.1 Million
Q4 2022 Feb 13, 2023	BUY	$9.89 - $12.7 $335,122 - $430,339	33,885 Added 1.27%	2,697,573 $32.9 Million
Q3 2022 Nov 14, 2022	SELL	$9.82 - $12.75 $298,655 - $387,765	-30,413 Reduced 1.13%	2,663,688 $27.8 Million
Q2 2022 Aug 12, 2022	BUY	$6.23 - $11.12 $34,022 - $60,726	5,461 Added 0.2%	2,694,101 $28.9 Million
Q1 2022 May 13, 2022	SELL	$7.89 - $12.48 $839,472 - $1.33 Million	-106,397 Reduced 3.81%	2,688,640 $25.5 Million
Q4 2021 Feb 08, 2022	SELL	$9.82 - $12.44 $353,156 - $447,379	-35,963 Reduced 1.27%	2,795,037 $32.3 Million
Q3 2021 Nov 15, 2021	SELL	$8.74 - $11.84 $1.09 Million - $1.47 Million	-124,285 Reduced 4.21%	2,831,000 $27 Million
Q2 2021 Aug 13, 2021	SELL	$8.71 - $10.72 $47,304 - $58,220	-5,431 Reduced 0.18%	2,955,285 $28.5 Million
Q1 2021 May 12, 2021	SELL	$9.2 - $23.86 $2.44 Million - $6.33 Million	-265,189 Reduced 8.22%	2,960,716 $29.3 Million
Q4 2020 Feb 11, 2021	SELL	$13.47 - $24.89 $1.06 Million - $1.96 Million	-78,592 Reduced 2.38%	3,225,905 $74.5 Million
Q3 2020 Nov 16, 2020	SELL	$12.89 - $15.89 $2.65 Million - $3.26 Million	-205,250 Reduced 5.85%	3,304,497 $46.7 Million
Q2 2020 Aug 14, 2020	BUY	$8.86 - $15.69 $1.26 Million - $2.23 Million	142,231 Added 4.22%	3,509,747 $52.9 Million
Q1 2020 May 14, 2020	BUY	$6.63 - $11.16 $256,362 - $431,523	38,667 Added 1.16%	3,367,516 $31.1 Million
Q4 2019 Feb 14, 2020	BUY	$7.48 - $10.75 $526,891 - $757,230	70,440 Added 2.16%	3,328,849 $32.4 Million
Q3 2019 Nov 13, 2019	BUY	$8.02 - $13.25 $4.8 Million - $7.93 Million	598,798 Added 22.51%	3,258,409 $26.1 Million
Q2 2019 Aug 13, 2019	BUY	$10.96 - $14.4 $1.5 Million - $1.97 Million	136,521 Added 5.41%	2,659,611 $33.2 Million
Q1 2019 May 13, 2019	BUY	$10.04 - $13.92 $810,227 - $1.12 Million	80,700 Added 3.3%	2,523,090 $34.3 Million
Q4 2018 Feb 12, 2019	SELL	$8.38 - $13.44 $29,221 - $46,865	-3,487 Reduced 0.14%	2,442,390 $23.4 Million
Q3 2018 Nov 14, 2018	BUY	$11.6 - $16.54 $596,089 - $849,940	51,387 Added 2.15%	2,445,877 $29.6 Million
Q2 2018 Sep 18, 2018	SELL	$13.13 - $17.09 $152,518 - $198,517	-11,616 Reduced 0.48%	2,394,490 $37.4 Million
Q2 2018 Aug 14, 2018	BUY	$13.13 - $17.09 $2.82 Million - $3.68 Million	215,060 Added 9.82%	2,406,106 $37.6 Million
Q1 2018 May 09, 2018	BUY	$13.76 - $17.12 $3.02 Million - $3.76 Million	219,558 Added 11.14%	2,191,046 $33 Million
Q4 2017 Feb 14, 2018	SELL	$12.51 - $16.24 $67,191 - $87,225	-5,371 Reduced 0.27%	1,971,488 $28.4 Million
Q3 2017 Nov 13, 2017	BUY	$11.74 - $15.78 $23.2 Million - $31.2 Million	1,976,859	1,976,859 $29.8 Million

Others Institutions Holding FOLD

# of Institutions

313

Shares Held

314M

Call Options Held

516K

Put Options Held

833K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.84B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Amicus Therapeutics, Inc. Transaction History